Theratechnologies (NASDAQ:THTX) Stock Price Down 0.6% – Here’s What Happened

Theratechnologies Inc. (NASDAQ:THTX) shares were down 0.6% during trading on Friday . The stock traded as low as $1.69 and last traded at $1.72. Approximately 84,056 shares were traded during mid-day trading, a decline of 45% from the average daily volume of 153,814 shares. The stock had previously closed at $1.73.

Theratechnologies Stock Performance

The business has a 50 day moving average of $1.55 and a two-hundred day moving average of $1.40. The stock has a market capitalization of $79.09 million, a PE ratio of -17.20 and a beta of 1.30.

Institutional Trading of Theratechnologies

An institutional investor recently raised its position in Theratechnologies stock. National Bank of Canada FI boosted its position in shares of Theratechnologies Inc. (NASDAQ:THTX) by 29.4% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 186,815 shares of the company’s stock after acquiring an additional 42,435 shares during the period. National Bank of Canada FI owned 0.41% of Theratechnologies worth $232,000 as of its most recent filing with the Securities & Exchange Commission.

About Theratechnologies

Theratechnologies Inc, a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen.